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When T cells are activated via the T cell receptor (TCR) complex a number of cellular substrates, 
including  some  cell  surface  proteins,  become  phosphorylated  on  tyrosine  (Tyr)  residues. 
Phosphorylation of cytoplasmic Tyr renders  these cell surface receptors competent to interact 
with proteins that link cell surface receptors to protein in the intracellular signaling pathways. 
Here we show that Tyr residues in the cytoplasmic domain of CD6 become phosphorylated upon 
T  cell activation via the TCR complex. Tyr phosphorylation was observed when the T  cells 
were activated by crosslinking CD3 or by cocrosslinking CD3 with CD2 or CD4, but not when 
the cells were stimulated by crosslinking CD2, CD4, or CD28 alone. Unlike other Tyr kinase 
substrates,  such  as  the phospholipase C~l-associated  pp35/36  protein,  whose level  of Tyr 
phosphorylation is highest when T  cells are activated by cocrosslinking CD3 with CD2, the 
levels of CD6 Tyr phosphorylation are highest when T  cells were activated by cocrosslinking 
CD3 with CD4. 
T 
he CD6 antigen is an *130-kD cell surface glycopro- 
tein expressed by peripheral blood T cells, thymocytes, 
a small subset of B cells, and some cells of the brain (1-6). 
We have recently reported the isolation and characterization 
of a cDNA clone encoding human CD6 (7). The predicted 
amino acid sequence of CD6 suggests that the mature pro- 
tein, obtained after  the removal of a 24-amino acid NHz- 
terminal signal peptide, has a 374-amino acid extracellular 
domain, a 26-amino acid hydrophobic membrane-spanning 
domain, and a 44-amino acid cytoplasmic domain. Compar- 
ison of the predicted amino acid sequence of CD6 with those 
of other published protein sequences indicated that CD6 is 
a member of a large family of proteins that includes the lym- 
phocyte cell surface glycoprotein CD5 (8) and the cysteine- 
rich domain of the type I macrophage scavenger receptor (9). 
At present, the function of the CD6 is not known. How- 
ever, a number of studies with anti-CD6 mAb suggest that 
CD6 plays an important role in T cell activation. The anti- 
CD6 mAb 2H1 has been shown to activate T cells in con- 
junction with PMA or with the anti-CD2 mAb Tl13 (2). 
Likewise,  the anti-CD6 mAb T12 can activate T  cells in a 
macrophage-dependent fashion (10). In addition, it has been 
shown that crosslinking of surface CD6 with an anti-CD6 
mAb and polyclonal goat anti-mouse Ig or rat anti-K chain 
can cause rapid mobilization of intracellular  Ca  2  § in T lym- 
phocytes, and that cocrosslinking CD6 with CD3 enhances 
CD3-mediated signaling (11, 12). 
MHC-restricted, antigen-specific activation of T cells via 
the TCR complex results in the rapid activation of a number 
ofintracellular kinases, including Tyr kinases (13). These ki- 
nases phosphorylate a number of protein substrates rendering 
them competent to interact with proteins that form part of 
the intracellular signal-transduction pathway.  Phosphoryla- 
tion of these proteins initiates a cascade of events whereby 
signals initiated by receptor-ligand interactions at the cell sur- 
face are communicated to the cell interior where they modu- 
late  the  effector  function of the  stimulated T  cell.  An- 
tiphosphotyrosine (Anti-p-Tyr) blots of lysates obtained from 
activated T cells have shown that upon T  cell activation, a 
discrete number of proteins become phosphorylated on Tyr 
residues (14). To date, only a few of these substrates have been 
identified. They include the ~" and e chains of the CD3 com- 
plex, phospholipase C(PLC) 3'1, CD5, ZAP-70, Raf-1, PI-3 
kinase, p95  '~', p60~, and p56  ~  (14-24).  Here we show that 
upon T  cell  stimulation, CD6  is phosphorylated on Tyr 
residues, rendering it competent to interact with proteins in 
the intracellular signaling pathways.  In addition, we show 
that when T lymphocytes are stimulated by crosslinking CD3 
alone, CD6 is weakly phosphorylated on Tyr residues. The 
level of p-Tyr CD6 is slightly increased ff the T cells are stimu- 
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the T cells are stimulated by cocrosslinking CD3 with CD4, 
the level of  p-Tyr CD6 is dramatically increased. We also found 
that the levels of Tyr phosphorylation of CD5 parallel those 
of CD6  after T  cell  stimulation. 
Materials and Methods 
Cells and Antibodies.  Fresh  peripheral blood lymphocytes from 
normal donors were isolated  by density gradient centrifugation and 
used to generate PHA-P blasts, mAb 9.6 (anti-CD2), G19-4 (anti- 
CD3), G17-2 (anti-CD4), 10.2 (anti-CD5), 9.3 (anti-CD28) (25, 
26), G3-6 (anti-CD6) (27), and an affinity-purified  rabbit anti-p- 
Tyr antibody have been previously described (28, 29). The mAb 
against CD2, CD3, CD4, and CD28 were biotinylated as previ- 
ously described (30). 
T  Cell Activation, Immunoprecipitation and Western Immunoblot- 
ring.  Peripheral  blood lymphocytes stimulated by PHA-P for 5 d 
(0.5/~g/ml, Wellcome  Diagnostics, Dartford, UK) were activated 
by crosslinking CD2, CD3, CD4, CD28, or co-crosslinking  CD3 
and CD2, or CD3 and CD4 using 10/~g/ml of the appropriate 
biotin mAb and 5/zg avidin//xg mAb (11, 12). The cells were im- 
mediately pelleted and lysed  in a modified RIPA buffer (31) sup- 
plemented with 1 mM PMSF, 1 mM sodium orthovanadate, and 
20 tlg/rrd aprotinin. Cell nuclei and debris were cleared at 10,000 
g for 10 min, and the cell lysates were incubated with either anti- 
CD5 or the anti-CD6 mAb for 2 h at 4"C. The immune com- 
plexes were incubated with protein A-Sepharose beads (Repligen 
Corp., Cambridge, MA) for 1 h. The immune complexes were 
washed twice in modified RIPA buffer and once in PBS, boiled 
in SDS sample  buffer with dithiothreitol, separated  by SDS-PAGE 
(8.5%), and subsequently  electroblotted  to PVDF membrane. After 
blocking the nonspecific  binding sites with a buffer containing 6% 
BSA, the immunoblots were incubated  with anti-p-Tyr  (0.25/~g/rrd) 
in the same buffer overnight at room temperature. The blots were 
rinsed twice in 10 mM Tris pH 7.4, 0.9% NaC1 (rinse buffer), 
once in rinse buffer containing 0.05% NP-40, and twice in rinse 
buffer. The blots were incubated with 0.5/zCi/ml 12SI-protein A 
(ICN Radiochemicals,  Costa Mesa, CA) in blocking buffer con- 
taining 6% BSA. The immunoblots were washed  as described  above 
and exposed to film (X-AR; Eastman Kodak Co., Rochester, NY) 
at  -70~  with intensifying screen overnight. 
Phosphoamino Acid Analysis.  5-d-old  PHA-P blasts were washed 
twice with phosphate-free Earle's salts media containing 10% dia- 
lyzed fetal bovine serum. The cells were resuspended in 20 ml of 
media containing 10 mCi of [32p]orthophosphate (PBS 13; Amer- 
sham Corp., Arlington Heights, IL) and incubated for 2 h at 37~ 
The ceUs were then either rested or activated  by crosslinking CD3 
with CD4, lysed, and the anti-CD6 immunoreactive material was 
precipitated with protein A agarose beads (Repligen Corp.). The 
immunoprecipitates were resolved  by SDS-PAGE (8.5%). The gel 
was dried on filter paper and autoradiographed for 1 h. Labeled 
proteins from both unstimulated and stimulated cells with a mo- 
lecular mass of ,,o130 kD (CD6) were excised from the gel. Phos- 
phoamino acid analysis  was performed as described (32). The la- 
beled phosphoamino  acids  were then resolved  by 2-dimensional  thin 
layer dectrophoresis  (32) on cellulose thin layer plates (VWR 
Scientific Corp., Philaddphia, PA), detected by autoradiography, 
and identified  by comigration  with ninlaydrin-stained  phosphoamino 
acid standards. 
Preclearing of  CD6 and CD5.  Anti-CD6 and -CD5 were directly 
conjugated to CNBr-activated Sepharose 4B (Pharmacia, Uppsala, 
Sweden) and incubated with cell lysates  from PHA-P blasts stimu- 
lated by cocrosslinking CD3 with CD4. The sequential immuno- 
precipitations were carried out as described above. After each im- 
munoprecipitation, the resulting lysate was incubated with more 
Sepharose-conjugated mAb, allowing the progressive depletion of 
the anti-CD6 and anti-CD5 immunoreactive material from the ly- 
sates. The crude lysates and the precleared lysates were then sub- 
jected to anti-CD6 and anti-CD5 immunoprecipitation, followed 
by SDS-PAGE and anti-p-Tyr immunoblotting as described above. 
Results and Discussion 
To investigate which T lymphocyte cell surface glycopro- 
teins become phosphorylated on tyrosine residues  upon T 
cell activation, T  cells were stimulated by crosslinking the 
T cell surface proteins CD2, CD3, CD4, and CD28, or by 
cocrosslinking CD3 with CD2 or CD4. After a 1-min stim- 
ulation period, the cells were lysed and treated with an anti- 
CD6 mAb and the immunoreactive material was precipitated 
with immobilized protein A. Crude cell lysates and the im- 
munoprecipitated material were resolved by SDS-PAGE, trans- 
ferred to a PVDF membrane, probed with the anti-p-Tyr anti- 
body and nSI-protein A, and exposed to film. The anti-CD6 
mAb  immunoprecipitated  a  protein  of •130  kD  which 
bound to the anti-p-Tyr antibodies in material obtained from 
lysates of T cells activated by crosslinking CD3 alone or by 
cocrosslinking CD3 with CD2 or CD3 with CD4, but not 
from material obtained from lysates of unstimulated T cells 
Figure  1.  CD6 is phosphorylated  on Tyr after  T cell  activation  via the 
TCR. Lysates  from unstimulated  T cells (lane 0), or T cells which  were 
stimulated by cross[inking CD2, CD3, CD4, or CD28, or by co- 
cross[inking  CD3 with either  CD2 (CD2 x  CD3) or CD4 (CD3 x  CD4) 
were prepared. Crude  lysates  (Lysate) or lysates  treated  with an anti-CD5 
(o~CD5) or an anti-CD6 (o~CD6) mAb followed  by precipitation  with im- 
mobilized protein A, were isolated  by SDS-PAGE, blotted onto PVDF 
membrane, probed with an anti-p-Tyr  antibody  followed  by nSl-protein 
A, and exposed to film. (Left)  Molecular  weight standards. 
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alone (Fig. 1). These results suggest that CD6 becomes Tyr 
phosphorylated after activating T  cells via the TCR com- 
plex, but not upon crosslinking other surface receptors such 
as CD28 which induces the phosphorylation of an '~95-kD 
protein (Fig.  1). 
Although crosslinking CD3 alone or cocrosslinking CD3 
with CD2 resulted in CD6 Tyr phosphorylation,  we observed 
that cocrosslinking CD3 with CD4 resulted in the highest 
levels of CD6 Tyr phosphorylation (Fig. 1). It is interesting 
that other Tyr kinase substrates such as the PLC3,1-associated 
pp35/36 protein are more effectively  Tyr phosphorylated after 
cocrosslinking CD3 with CD2 (Fig.  1). These results sug- 
gest that differential receptor engagement during cellular in- 
teractions results in the phosphorylation of different Tyr ki- 
nase substrates. 
To confirm the presence of p-Tyr residues on CD6, T cells 
were incubated for 2 h in the presence of [32P]orthophos- 
phate and tither rested or stimulated by cocrosslinking CD3 
with CD4. The anti-CD6 mAb immunoreactive material from 
these cells was precipitated  with immobilized protein A, 
resolved  by SDS-PAGE, hydrolyzed, and labeled  phosphoamino 
adds were separated  via two-dimensional thin-layer electropho- 
resis. As shown in Hg. 2, CD6 was phosphorylated on Ser 
and Thr on unstimulated T cells (Fig. 2 A) and became phos- 
phorylated on Tyr (Fig. 2 B) after T cell stimulation. Previ- 
ously, Swack et al. (10) showed that CD6 in Con A-activated 
T cells is phosphorylated on Ser residues. Our results indi- 
cate that T  cell activation  via the TCR complex results in 
CD6 Tyr phosphorylation and slightly higher levels of Set 
phosphorylation (Fig. 2). The cytoplasmic domain of CD6 
contains two Tyr residues (7) which could be phosphorylated. 
Comparison of the amino acid sequence surrounding these 
two Tyr and those surrounding the Tyr, which are autophos- 
phorylation substrates in the src family kinases (33), did not 
provide information as to which of the two CD6 Tyr residues 
is the preferred  substrate  for Tyr kinases. 
To investigate if CD6 accounted for the strong ~130-kD 
protein seen in anti-p-Tyr blots of whole cell lysates after T 
cell stimulation, lysates from stimulated T  cells were pro- 
gressively  depleted of CD6 by multiple immunoprecipitations. 
The starting lysate and the precleared lysates and the anti- 
Figure  2.  CD6  in  unstimu- 
lated T cells is phosphoryhted on 
Set and Thr, T cell activation via 
the TCR complex results in Tyr 
phosphoryhtion.  Lysates  from un- 
stimulated  (A) or stimuhted (B) 
T cells which had been incubated 
in  the  presence  of  [32P]ortho- 
phosphate were resolved by SDS- 
PAGE. The phosphorylated  protein was detected by autoradiography, ex- 
cised from the gel, hydrolyzed, and resolved by 2-dimensional thin layer 
dectrophoresis.  Phosphorylated amino acids were detected by autoradiog- 
raphy. (Arrows)  Phosphoserine (5"), phosphotlL,  eonine (7"), and phosphotyro- 
sine (Y). 
Figure  3.  CD6 is  the only '~130-kD protein  to become Tyr phos- 
phorylated  after activating  T  cells via the TCR complex.  Lysates from 
T  cells that were stimulated  by crosslinking CD3 and CD4 and treated 
with no antibody or sequentially treated with an anti-CD6 mAb followed 
by protein A agarose. The untreated  lysate (lane O, CD6 Precleared Ly- 
sates), the anti-CD6 precleared lysates from each sequential immunoprecipi- 
tations (lanes 1-3, CD6 P-recleared  Lysates), and the anti-CD6-reactive  ma- 
terial from each sequential immunoprecipitation  (lanes I-3,  CD6 IPS), 
were resolved by SDS-PAGE, blotted, and treated with an anti-p-Tyr anti- 
body followed by 12Sl-protein A and exposed to film. Similarly, lysates 
from activated T cells were sequentially treated with an anti-CD5 mAb 
followed by protein A. The untreated lysate (lane 0, CD5 Precleared  Lysate) 
and the anti-CD5 precleared lysates from each sequential immunoprecipi- 
ration (lanes 1-3, CD5 Precleared  Lysates  ) were analyzed as described above. 
CD6 immunoreactive material from each immunoprecipita- 
tion were analyzed by SDS-PAGE followed by Western blot- 
ting using anti-p-Tyr antibodies and t~SI-protein A (Fig. 3). 
Our results indicate that within the detection limits of our 
experiment, CD6 is the major T cell protein of ~130 kD, 
which becomes phosphorylated on Tyr after T cell stimula- 
tion via the TCR complex. 
Parallel CD5 immunoprecipitation and anti-p-Tyr  blots were 
carried out with lysates prepared from unstimulated or stimu- 
lated T cells (Figs. 1 and 3, data not shown). CD5 Tyr phos- 
phorylation was observed when T cells were stimulated by 
crosslinking  CD3, or by cocrosslinking  CD3 with CD2 or 
CD3 with CD4, but not from lysates from unactivated  T 
cells or T cells activated  by crosslinking CD2, CD4, and CD28 
alone (Figs. 1 and 3). These results confirm and extend the 
results of Davies et al. (18) who showed that stimulation of 
T cells by crosslinking CD3 resulted in the Tyr phosphoryla- 
tion of CD5. As was observed for CD6, CD5 is most effec- 
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crosslinking CD3 with CD4. However, the Tyr phosphory- 
lation level of CD6 was consistently higher than that of CD5 
after T cell stimulation (Fig. 1). CD5 and CD6 are homolo- 
gous proteins and their expression is tightly linked (7). The 
observation that  the levels of Tyr phosphorylation of these 
two proteins parallel each other after T cell stimulation, sug- 
gests that  the function of these two proteins may be simi- 
larly regulated. 
The data presented herein show that activation of T cells 
via the TCR complex, but not by other receptors such as 
CD2 or CD28, results in different levels of Tyr phosphoryla- 
tion on the T cell surface proteins CD6 and CD5. It is likely 
that Tyr phosphorylation may play an important role in the 
ability of these two proteins  to mediate their functions  as 
accessory molecules in T  cell activation,  and possibly affect 
their ability to signal to other cells by modulating their in- 
teraction with  their counter receptors.  Recently, Beyers et 
al. (34) described the formation of a loosely associated mul- 
timolecular complex between the TCR and the T  cell sur- 
face proteins CD2,  CD4, CD5, CD8,  and the cytoplasmic 
Tyr kinases  p56  la  and  p60~.  Two  additional  proteins  of 
~34 and ,,o105 kD were also observed to associate with this 
complex. Cardenas et al. (35) have shown that resting T cells 
express an * I05-kD form of CD6. This report leads us to 
postulate that the ,,ol05-kD protein found to be associated 
with the TCK multimolecular complex may be CD6.  The 
observation that  stimulating  T  cells by cocrosslinking in- 
dividual  components  of the  TCK  complex results  in  the 
differential phosphorylation of proteins loosely associated with 
the TCK complex may indicate that proteins within this mul- 
timolecular complex are spatially segregated and/or  that  a 
subset of the TCR-associated Tyr kinases may be preferen- 
tially activated depending on which cell surface proteins were 
engaged during activation.  From a functional standpoint, these 
differences in Tyr phosphorylation may provide a molecular 
mechanism whereby the TCK complex is able to differen- 
tially engage the intracellular signaling pathways based upon 
which of its components participate  in cellular contact. 
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